| Authors | X Leleu, G Fouquet, B Hebraud, M Roussel, D Caillot, M L Chrétien, B Arnulf, R Szalat, L Garderet, L Benajiba, B Pegourie, C Regny, B Royer, A Caulier, A M Stoppa, S Garciaz, C Touzeau, C Chaleteix, J P Fermand, H A Loiseau, T Facon, M Attal, P Moreau, Intergroupe Francophone du Myélome (IFM) |
| Journal | Leukemia
(Leukemia)
Vol. 27
Issue 11
Pg. 2242-4
(Nov 2013)
ISSN: 1476-5551 [Electronic] England |
| PMID | 23558525
(Publication Type: Letter, Multicenter Study)
|
| Chemical References |
- Boronic Acids
- Pyrazines
- Thalidomide
- Bortezomib
- Dexamethasone
|
| Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Boronic Acids
(administration & dosage)
- Bortezomib
- Combined Modality Therapy
- Dexamethasone
(administration & dosage)
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Middle Aged
- Multiple Myeloma
(mortality, pathology, therapy)
- Neoplasm Staging
- Prognosis
- Pyrazines
(administration & dosage)
- Remission Induction
- Retrospective Studies
- Survival Rate
- Thalidomide
(administration & dosage)
- Transplantation, Autologous
|
